Nervous System Neoplasms  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nervous System Neoplasms
NCT00652990: Sirolimus to Treat Plexiform Neurofibromas in Patients With Neurofibromatosis Type I

Active, not recruiting
2
18
US
Sirolimus
University of Alabama at Birmingham, National Cancer Institute (NCI)
Neurofibromatosis Type 1, Plexiform Neurofibromas, Paraspinal Plexiform Neurofibromas
08/14
08/14
NCT00831324: Everolimus in Treating Patients With Recurrent or Progressive Low-Grade Glioma

Recruiting
2
60
US
everolimus, immunohistochemistry staining method, laboratory biomarker analysis
University of California, San Francisco
Brain Tumor
01/16
01/17
NCT01386450: AZD6244 in Children With Low-Grade Gliomas

Recruiting
2
18
US
AZD6244
National Cancer Institute (NCI)
Optic Glioma, Pilocytic Astrocytoma, Low Grade Glioma, Fibriullary Astrocytoma
10/16
11/18

Download Options